JBC Origene Your Gene Company

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M704194200 on July 24, 2007

J. Biol. Chem., Vol. 282, Issue 38, 27923-27934, September 21, 2007
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
282/38/27923    most recent
M704194200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jiang, L.
Right arrow Articles by Kelleher, N. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jiang, L.
Right arrow Articles by Kelleher, N. L.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Global Assessment of Combinatorial Post-translational Modification of Core Histones in Yeast Using Contemporary Mass Spectrometry

LYS4 TRIMETHYLATION CORRELATES WITH DEGREE OF ACETYLATION ON THE SAME H3 TAIL*Formula

Lihua Jiang{ddagger}§1, Jonell N. Smith{ddagger}, Shannon L. Anderson§, Ping Ma§||, Craig A. Mizzen§2, and Neil L. Kelleher, The laboratory of this author was supported by National Institutes of Health Grant GM 067193, the Packard Foundation, the Alfred P. Sloan Foundation, and a 2004 Camille Dreyfus Teacher-Scholar Award from the Dreyfus Foundation{ddagger}§3

From the {ddagger}Department of Chemistry, Department of Cell and Developmental Biology, ||Department of Statistics, and §Institute of Genomic Biology, University of Illinois, Urbana, Illinois 61801

Received for publication, May 22, 2007 , and in revised form, July 17, 2007.


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
A global view of all core histones in yeast is provided by tandem mass spectrometry of intact histones H2A, H2B, H4, and H3. This allowed detailed characterization of >50 distinct histone forms and their semiquantitative assessment in the deletion mutants gcn5{Delta}, spt7{Delta}, ahc1{Delta}, and rtg2{Delta}, affecting the chromatin remodeling complexes SAGA, SLIK, and ADA. The "top down" mass spectrometry approach detected dramatic decreases in acetylation on H3 and H2B in gcn5{Delta} cells versus wild type. For H3 in wild type cells, tandem mass spectrometry revealed a direct correlation between increases of Lys4 trimethylation and the 0, 1, 2, and 3 acetylation states of histone H3. The results show a wide swing from 10 to 80% Lys4 trimethylation levels on those H3 tails harboring 0 or 3 acetylations, respectively. Reciprocity between these chromatin marks was apparent, since gcn5{Delta} cells showed a 30% decrease in trimethylation levels on Lys4 in addition to a decrease of acetylation levels on H3 in bulk chromatin. Deletion of Set1, the Lys4 methyltransferase, was associated with the linked disappearance of both Lys4 methylation and Lys14 and Lys18 or Lys23 acetylation on H3. In sum, we have defined the "basis set" of histone forms present in yeast chromatin using a current mass spectrometric approach that both quickly profiles global changes and directly probes the connectivity of modifications on the same histone.


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
In eukaryotic cells, genetic information is complexed with histone proteins in a highly organized structure known as chromatin. The nucleosome, the fundamental structural unit of chromatin, contains an octamer formed by two copies of each of the core histones H2A, H2B, H3, and H4, about which is wrapped 146 bp of DNA (1). The dynamics of chromatin structure directly influence the accessibility of DNA, which in turn affects gene transcription, replication, and recombination (2). Core histone proteins are evolutionarily conserved and have flexible N-terminal tails protruding from the nucleosome. These tails are subject to a variety of post-translational modifications (PTMs)4 such as phosphorylation, ubiquitination, methylation, and acetylation (3). Such PTMs change the interactions of histone proteins with DNA and chromatin remodeling complexes, which are responsible for diverse functions within the cell (4). Different combinations of covalent modifications form the essence of what has been termed the histone code (5).

Acetylation is perhaps the best characterized PTM on histones and generally is associated with increased DNA accessibility not only by the neutralization of the positive charges on lysine residues but also as interaction sites capable of recruiting chromatin remodeling complexes (6). Previous studies have shown that particular histones and particular sites within histones become acetylated under distinct physiological conditions (7). The selection of acetylation sites could be accomplished either by a set of different histone acetyltransferases (HATs) or by the fine tuning of HAT specificity by additional factors. So far, a variety of proteins with HAT activity have been discovered in Saccharomyces cerevisiae (6, 8), but their in vivo substrate specificities have only been partially investigated by antibodies against some of the known acetylation sites (9). It is still a major challenge to define the global impact on each histone's PTM pattern upon cellular perturbation (e.g. a HAT knock-out). A study of HAT deletion effects using a method with less bias (i.e. one that can visualize all abundant PTMs simultaneously in an unbiased fashion) and still provide site-specific PTM information will help our understanding of how HATs work together in vivo and illuminate the interplay between acetylation and other PTMs.

Gcn5 was first shown to be required for transcriptional activation and later recognized to have HAT activity (10). To date, it is one of the best characterized HATs both structurally and functionally. Recombinant Gcn5 acetylates free H3 at Lys14 preferentially and H4 at Lys8 and Lys16 weakly in vitro, confirming the selectivity of Gcn5 for certain lysine residues within specific histones (11). For histone H3, this specificity is extended to other sites (Lys9, Lys14, Lys18, and Lys23) when Gcn5-containing complexes, such as SAGA and ADA, are used with nucleosome substrates in vitro (12), indicating that its HAT activity is regulated by interacting proteins. Later, the Grunstein laboratory used highly specific antibodies to reexamine the substrate specificity of Gcn5 in vivo (9). Their study demonstrated that Gcn5 is required for acetylation at Lys11 and Lys16 of H2B and Lys9, Lys18, Lys23, and Lys27 of H3 with the exception of Lys14. In the course of these studies, almost no effect on H4 (9, 13) was found, whereas others support that Gcn5 deletion can affect acetylation of H4 in addition to H3 (14). These results are informative but do not reveal if the acetylation sites affected by Gcn5 are on the same histone molecule or whether they are affected equivalently, because antibodies can only detect one PTM at a time and different antibodies have different affinities. Even when antibodies showed no change of modification at one site, there could be change of combinations of modifications. Due to the limitations of antibodies, a more informative and precise method is necessary to fully understand the substrate specificity of Gcn5.

Previous studies have shown a direct correlation between Gcn5 HAT activity and activation of specific model genes, including HIS3, PHO5, and HO (15-17). A more comprehensive understanding of Gcn5 HAT activity utilized microarray analysis to show expression differences for over 60% of genes in yeast (18, 19). A combination of serial analysis of gene expression and chromatin immunoprecipitation methods has shown that Gcn5 plays a global role in regulating histone H3 and H4 acetylation (20). However, direct measurements of the effect of Gcn5 on the global levels of PTMs on all core histone proteins have not been described.

Here, we used top down mass spectrometry (21, 22) to examine the global effects of Gcn5 and eight other mutants on the expression and modification of all four core histone proteins. We first established the "basis set" of all abundant PTM combinations on intact histones in wild type cells, including site-specific PTM localization, using electron capture dissociation (ECD) for tandem mass spectrometry (23, 24). Recently, this general approach has been demonstrated on diverse forms of human histones (25-27), with quantitative determination of specific combinations of modifications and PTM occupancy at specific sites (including the ability to resolve "positional isomers" of acetylation for H4) (28). Besides characterizing all core histones, ECD analysis of the H3 tail from wild-type chromatin also revealed a correlation between methylation and acetylation; there is a wide swing from 10 to 80% Lys4 trimethylation levels on the species with 0 and 3 acetylation states, respectively.

With the top down perspective, global alteration of histone modification in gcn5{Delta} cells was striking and readily apparent; levels of hyperacetylated forms of H2B and H3 were greatly diminished, whereas acetylation of H4 and H2A was only slightly affected. gcn5{Delta} cells showed reduced acetylation at specific sites in H3 and a 30% decrease in the overall trimethylation level on Lys4, underscoring the reciprocity between these two chromatin marks. Set1 mutants also showed the loss of acetylation at Lys14 and Lys18 or Lys23 on the same molecules where Lys4 trimethylation was also lost. Results from eight other mutants are also presented and highlight the potential to profile a large number of conditions for their effects on bulk chromatin.


    EXPERIMENTAL PROCEDURES
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Yeast Cell Culture—S288C S. cerevisiae cells (MATa his3{Delta} leu2{Delta} met15{Delta} ura3{Delta}) with the interruption of Gcn5, Ahc1, Rtg2, Ada1, Spt7, Ard1, Nat1, or Nat4, respectively, were purchased from Open Biosystems. All of the strains were grown in YPD (1% yeast extract, 2% bactopeptone, 2% glucose, pH 7) at 30 °C to midlog phase until A600 = 0.6 units. Growth curves of wild type and gcn5{Delta} cells were established by recording cell density at A600 every 1.5 h. Cells were harvested by centrifugation at 4 °C for 5 min at 1000 x g and washed twice with sterile water before storage of the cell pellets at -80 °C.

Set1 mutant MBY1217 (MAT{alpha} his3{Delta}200 ade2::hisG leu2{Delta} ura2{Delta}0 met15{Delta}0 trp1{Delta}63 Ty1his3AI-236r, Ty1ade2AI515 set1{Delta}::TRP1) and the parental strain were obtained from the laboratory of Scott Briggs (Purdue University). Construction of plasmids expressing full length Set1-(1-1080) and the N-terminal truncated Set1-(829-1080) were described in previous studies (29, 30). Cells were grown on SC medium (0.67% (w/v) yeast nitrogen base supplemented with amino acids, 2% glucose) lacking uracil to midlog phase until an A600 of 0.6 units. Cells were harvested as described above.

Histone Extraction and Separation—Frozen cell pellets were thawed on ice and extracted three times with 2.5 volumes of yeast protein purification reagent (Yper; Pierce), 0.1 M dithiothreitol, 5 nM microcysteine (Sigma), 500 µM 4-(2-aminoethyl)-benzenesulfonyl fluoride (Roche Applied Science) and 100 mM sodium butyrate. Briefly, resuspended cells were incubated on ice for about 30 min, lysates were clarified by 5 min of centrifugation at 18,000 x g at 4 °C, and the supernatant was removed. Following two additional repetitions, the cytoplasm-reduced cell pellet was then washed three times with sterile water to remove excess Yper. Histone extraction was performed twice by incubation of the cell pellet with 2.5 volumes of 8 M deionized urea and 0.4 N sulfuric acid for 30 min on ice. The sample was spun down again, and clarified supernatants were pooled and immediately loaded onto an equilibrated disposable C4 column (J. T. Baker Inc. BAKERBOND sptTM wide pore butyl (C4) disposable extraction column). After washing the column with 10 volumes of buffer A (0.1% trifluoroacetic acid in distilled H2O), histones were eluted with buffer B (60% acetonitrile, 0.1% trifluoroacetic acid). Acetonitrile was then removed from the collected fractions using a SpeedVac.

Before further separation by RPLC, the sample was oxidized by incubating at room temperature in 3% formic acid and H2O2 for 4 h (31). Oxidized protein was loaded onto a 4.6-mm x 250-mm C8 or C18 Vydac column. Proteins were fractionated in 100 min from 30 to 60% B (A, 5% CH3CN with 0.1% trifluoroacetic acid; B, 90% CH3CN with 0.094% trifluoroacetic acid) and detected by absorbance at 214 nm. Histone proteins were eluted between 55 and 95 min (Fig. 1A). Every fraction was subsequently concentrated in a SpeedVac.


Figure 1
View larger version (32K):
[in this window]
[in a new window]

 
FIGURE 1.
HPLC separation and MS detection of intact histone H4 and H2A from WT and gcn5{Delta} cells. A, chromatogram of WT whole cell histone extract. Proteins were fractionated by reverse phase HPLC, and elution was monitored at absorbance of 214 nm. B and C, broadband MS data of WT H4 and H2A. D and E, broadband MS data of gcn5{Delta} H4 and H2A. The asterisk indicates an artificial phosphate adduct (+98 Da) of the 1 Ac form. 1 Ac is N-terminal acetylation.

 
Different acetylation states of H3 were further separated by acid urea gel electrophoresis using gels composed of 15% Triton X-100, acetic acid, urea (typically 1.5-mm thick and 13 x 14 cm2) according to Mullen et al. (32), except that gels were run at 250 V for 20 h to obtain better resolution of H3. Proteins were visualized by Coomassie Blue staining. A duplicate gel was transferred to polyvinylidene difluoride and probed with anti-Lys4 trimethylation antibodies (Abcam).

H3 Glu-C Digestion and RPLC Separation—H3 purified from RPLC was dried down and resuspended in 50 µl of 25 mM NH4HCO3 buffer (pH 4). Glu-C (Roche Applied Science) was added at a ratio of Glu-C/H3 of 1:10 (w/w) and incubated at room temperature for 4-5 h. The reaction was stopped by freezing the sample. H3 digests were loaded to a 4.6 mm x 250 mm C18 Vydac column pre-equilibrated with 0.2% trifluoroacetic acid. Peptides were fractionated in 60 min from 0 to 60% B (90% acetonitrile with 0.188% trifluoroacetic acid) and detected by absorbance at 214 nm (Fig. 3A).

Mass Spectrometry: ESI/Quadrupole-FTMS—Purified and dried histone samples were resuspended in 50 µl of ESI solution (50% acetonitrile, 49% H2O, and 1% formic acid), and 10 µl was loaded to a nanospray robot (Advion BioSciences, Ithaca, NY). The system used in this study was a custom 8.5 T quadrupole-FTMS hybrid described elsewhere (24). Ions from ESI were directed through a heated metal capillary and multiple ion guides into the ion cell (~10-10 torr) of the FTMS system. Theoretical isotopic distributions were generated using IsoPro version 3.0 and fit to experimental data by least squares to assign the most abundant isotopic peak. Typically, 10-50 scans were used to collect broadband data. Samples were also analyzed using a quadrupole-based selection strategy. In short, targeted peaks were selected by a quadrupole filter before accumulation (1-2 s) in an external octupole and transfer to the ion cell. Ions were fragmented by ECD (23). Most spectra were stored as 512,000 data points and processed using zero or one truncation, no zero fill, and Hanning apodization. MS/MS data were analyzed by a modified version of the THRASH algorithm. Individual histone proteins were identified and characterized by uploading data onto the prosightptm World Wide Web server to search the yeast data base.

Statistical Comparison with ChIP-on-chip Data—To cross-validate our findings, we compared our results with publicly available data. In a recently published paper, genome-wide histone acetylation levels of H3 at Lys9 and Lys14 and methylation levels of H3 at Lys4 of wild type yeast in rich medium (YPD) were measured using ChIP-on-chip (33). The average expression ratios of immunoprecipitated DNA to control DNA across experimental replicates were downloaded from the World Wide Web. After a log2 transformation of Lys9 and Lys14 acetylation level and Lys4 trimethylation level, a plot comparing the acetylation (Lys9 and Lys14) and methylation (Lys4) levels at 3,581 intergenic regions was obtained for subsequent analysis (34).


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Histone Extraction and Purification—Extraction of histones from yeast cells is widely known to be more problematic than from mammalian cells. Waterborg and colleagues (35) have described a quick method for yeast histone preparation, but in our hands the yield is less than 50% of expected (data not shown). To address this limitation, we designed a simplified procedure that relies on the observation that yeast chromatin is not readily solubilized when the cell wall is intact. Thus, we used a mixture of nonionic detergents to deplete cells of the nonhistone proteins and then used conventional acid extraction in the presence of 8 M urea to prepare crude histone from the residual cell pellet. By using this method, more than 95% histone recovery histone was confirmed through Western blot analysis using an antibody to hyperacetylated H4 (data not shown). Oxidation of samples before RPLC separation helped to resolve each histone to a single chromatographic peak (Fig. 1A), with H3 giving two peaks later during the RPLC run (see below). The PTM profiles obtained from intact histones did not change appreciably upon repeated sampling, confirming that differentially modified forms of intact histones co-elute during reversed phase separation (35); this enables quantitative determination of PTM profiles using top down MS (25-27). For WT and mutant cells described below, results are presented for intact profiles first, followed by site-specific PTM localization using MS/MS.

Effects of Gcn5 Deletion on H4 Acetylation—To date, there have been inconsistent results when assessing the effect of Gcn5 on histone H4. By using antibodies specific for each acetylated site, Roth and co-workers (14) showed that deletion of Gcn5 caused a diminution of acetylation at each of the four acetylation sites in H4. Other studies have shown that Gcn5 does not acetylate H4 in vivo and in vitro (9, 13). In order to clarify these issues, we compared H4 modification forms from wild type and gcn5{Delta} cells. To begin, we acquired high resolution, intact mass spectra of histone H4 (Fig. 1B). The H4 modification profile showed that the majority of H4 (>85%) is acetylated with di- and triacetylated forms as the dominant modification forms, which is consistent with a much larger fraction of the yeast genome actively being transcribed versus mammalian histone H4 (22). Gcn5 deletion results in very slight reduction in global H4 acetylation (Fig. 1, B versus D). This result is consistently reproducible (n = 5) and appears to be near the limit of the FTMS-based assay to reliably detect changes in PTM patterns. These results indicate that Gcn5 deletion has only a marginal effect on the global H4 acetylation pattern in vivo.

To determine which lysine sites were acetylated, we performed ECD on each acetylation state (states 1-5) from WT and gcn5{Delta} cells. In WT cells, the 1 Ac form was N-terminally acetylated (data not shown). Modifications on the 2 Ac form were localized to the N terminus and Lys16. For the 3 Ac form, Lys12 was acetylated in addition to the initial two acetylations (supplemental Fig. S1, A and B). The 4 Ac form was acetylated at Lys8 in addition to acetylation sites in the 3 Ac form (supplemental Fig. S1C). In the 5 Ac form, N terminus, Lys16, Lys12, Lys8, and Lys5 were all acetylated (data not shown). All acetylation forms were found to be pure species; no acetylation isomers were detected (28). The directionality of acetylation is rigorously a C->/N-terminal zipper (i.e. Lys16 ->/Lys12 ->/Lys8 ->/Lys5) in both WT and gcn5{Delta} cells. We conclude that Gcn5 deletion only slightly reduces the relative abundance of each acetylation form on H4 and does not affect residue specificity of acetylation.


Figure 2
View larger version (27K):
[in this window]
[in a new window]

 
FIGURE 2.
Mass spectra of intact H2B from WT and gcn5{Delta} cells. A and B, broadband MS of H2B modification patterns in WT and gcn5{Delta} cells, respectively. C and D, graphical fragment maps for ECD MS/MS results of the 1 Ac form of H2B.1 and H2B.2, respectively. All of the z ions are unmodified, and c ions have a mass difference of +42 Da from the theoretical c ions, indicating N-terminal acetylation. E, reduced representation of H2B N-terminal acetylation.

 
Gcn5 Deletion: Effect on H2A—There are two H2A gene products, H2A.1 and H2A.2, and one H2A.Z variant in yeast cells. H2A.1 and H2A.2 have exactly the same mass and the same protein sequence, apart from a C-terminal switch of an Ala-Thr in H2A.1 to a Thr-Ala in H2A.2. Combining the intact protein profile (Fig. 1C) and ECD data of each form reveals that the most abundant form is N-terminally acetylated, followed by the form with N-terminal and Lys7 acetylation. The form with three acetylations is present at very low abundance, and after digestion with Glu-C, the site was localized to Lys4 (data not shown). Most studies suggest that Gcn5 has no effect on H2A acetylation, but others have suggested that Gcn5 may have some role in H2A acetylation (9). Our data show no detectable changes in the acetylation level of H2A upon Gcn5 disruption (Fig. 1, C versus E). H2A.Z was shown to be present in two adjacent nucleosomes in most yeast gene promoters (36), but H2A.Z levels are too low for detection by the MS approach employed here. However, Millar et al. have shown that Gcn5 affects acetylation on Lys14 of H2A.Z (37).


Figure 3
View larger version (42K):
[in this window]
[in a new window]

 
FIGURE 3.
Change of modification profiles of H3 assessed by MS, acid-urea electrophoresis, and Western blotting. A and B, MS of intact H3 modification profiles in WT and gcn5{Delta} cells. C, acid urea gel of intact histone H3 from WT and gcn5{Delta}. D, Western results from using an anti-Lys4 trimethylation antibody to visualize an analogous acid urea gel analogous to that in C.

 
H2B from WT and gcn5{Delta} Cells—There are two H2B forms present in yeast, H2B.1 and H2B.2, with a mass difference of 15 Da. Previous studies revealed that 6 lysines can be acetylated on each gene product, with the specific HATs responsible for individual acetylations not yet all known. Using top down MS, up to five acetylations were observed on H2B.1 and H2B.2 (Fig. 2A). Due to the low abundance of the forms with six acetylations, they were not obvious in the "broadband" FT mass spectrum. However, after signal enhancement using selected ion accumulation, which increases the dynamic range by ~50-fold (21, 38), these species were detectable (data not shown). For both H2B.1 and H2B.2, monoacetylation was the most abundant form, and the abundance of other forms decreased with increasing acetylation. Using top down MS to monitor the relative abundance of all forms at once, a spectrum of H2B from gcn5{Delta} cells showed strikingly that all forms with >1 acetylation were undetectable (Fig. 2B) except for a minor amount of 2 Ac forms, even when selected ion accumulation was used (data not shown).

Previous studies have shown that Lys6, Lys11, Lys16, Lys17, Lys21, Lys22, and the N terminus of H2B can be acetylated. Tandem mass spectrometry (MS/MS) using electrons for ion dissociation was performed on the mono-, di-, tri-, and tetra-acetylated forms. ECD data of the monoacetylation forms from WT and gcn5{Delta} cells showed that both were acetylated exclusively at the N terminus (Fig. 2, C and D). ECD of the diacetylation form from the WT sample indicated the presence of acetylation "isomers" with partial occupancy on Lys16 and Lys16 (supplemental Fig. S2A). The percentage of each isomer was determined by comparing the abundance of fragment ions that arise from backbone cleavages between these sites (28). The data show that the second acetylation was split, with 60% occupancy on Lys22 and 40% occupancy on Lys16 (with the first acetylation 100% on the N terminus). The same method applied to triacetylated H2B showed that the N terminus and Lys16 were acetylated at 100% occupancy, whereas the third acetylation was split 60% at Lys11 and 40% at Lys22 (Supplemental Fig. S2B). In the tetra-acetylated forms, all of the Lys11, Lys16, and Lys22 were acetylated (supplemental Fig. S2C). Due to the low abundance of the 5 Ac and 6 Ac forms, reliable ECD data have not been acquired to date. These results indicate that acetylation of Lys6, Lys11, Lys16, Lys17, and Lys22 in H2B are lost upon deletion of Gcn5.

WT H3 and Effects of Gcn5 Deletion—For WT S. cerevisiae extracted with our new procedure, two H3 peaks were consistently observed in all of our RPLC chromatograms (Fig. 1A, far right), whereas other histone extraction methods only yield one H3 peak (35). FT mass spectra showed that the modification profiles of these two HPLC peaks are different (supplemental Fig. S3). The reason for the elution differences between these two peaks is unknown at the current time. Considering that the nominal mass of three methylations is the same as one acetylation (+42 Da), these peaks could differ in the levels of different modifications and/or their site isomers. Thus, to simplify sample comparisons, we combined these two H3 HPLC peaks (displayed separately in supplemental Fig. S3) for all sample comparisons reported below.

As shown in Fig. 3, A and B, the modification profiles for H3 in gcn5{Delta} cells showed that the relative abundance of peaks with {Delta}m values of +126, +168, and +210 Da above the unmodified form decreased detectably. Consistent with a large body of literature on Gcn5 deletion, it seemed likely that these decreases were attributable primarily to H3 hypoacetylation. However, recently Zhang et al. (39) showed that histone methylation is also correlated with acetylation, suggesting that the change could be caused by decreased methylation on Lys4 or Lys79 as well. In order to assess this with an orthogonal method, we compared these MS profiles with the resolution achieved on acid urea gels, well known for the ability to resolve histones according to acetylation state (32). Based on the Coomassie-stained gel of Fig. 3C, H3 from gcn5{Delta} cells clearly has less acetylation versus that from WT cells. To correlate these acetylation states with trimethylation at Lys4 (K4me3), the anti-K4me3 antibody was used to probe a transfer from an analogous gel. This suggested that less K4me3 occurred in gcn5{Delta} cells (Fig. 3D), but extracting quantitative information about the specific acetylation states was challenging. In order to quantify the relationship between acetylation and methylation states, we performed ECD on the bulk H3 from both wild type and gcn5{Delta} cells.


Figure 4
View larger version (29K):
[in this window]
[in a new window]

 
FIGURE 4.
MS results of 1-50 aa of H3 from WT and gcn5{Delta} cells. A, HPLC profiles of Glu-C digested H3 from WT and gcn5{Delta} cells. The top trace is from WT H3, and the bottom one is from gcn5{Delta} H3. Peaks 1-3 contain the 1-50 aa of H3. Peak 3 was not observed in the gcn5{Delta} cells. B, MS of three different HPLC peaks that contain 1-50 aa of Glu-C-digested WT H3. C, MS results 1-50 aa of pooled H3 HPLC fractions from WT and gcn5{Delta} cells. D, the change of Lys4 trimethylation level at 0, 1, 2, and 3 acetylation states of WT H3. Modification level on Lys4, Lys9, Lys14, Lys18, and Lys23 from 0 Ac to 3 Ac state are listed in Table 1. These results are based on pooled H3 HPLC fractions 1-3. Asterisks, noise spikes.

 
With direct ECD fragmentation of all intact H3 isoforms en masse, each acetylation site is difficult to assess in isolation from one another (27). Therefore, we used endoproteinase Glu-C to liberate the H3 peptides corresponding to the 1-50 aa (40), 51-59 aa, and 74-94 aa segments, which collectively contain almost all known modification sites. Mass spectrometry identified one major peak in the chromatogram corresponding to H3 1-50 aa in both WT and gcn5{Delta} H3 digests (Fig. 4A). In addition to the major HPLC peak at ~30 min, two "satellite" peaks at 30.5 and 31.5 min were identified to be heavily acetylated forms of the 1-50 aa piece of WT H3 (see Fig. 4B). In Glu-C digests of H3 from gcn5{Delta} cells, both satellite peaks were typically missing, with the 30.5 min peak observable only if we doubled our conventional loading. Although these two satellite peaks are low in abundance (<10 milliabsorbance units at 214 nm), the data are reproducible. To further characterize the modifications on those heavily modified species, we combined peaks 2 and 3 and performed bulk ECD on all of these forms together. Bulk ECD results on the hypermodified forms in these fractions showed that 55% of Lys4 and 20% of Lys36 were trimethylated, 75% of Lys18 was acetylated, and all of the other lysine residues (Lys9, Lys14, Lys23, and Lys27) were 100% modified (supplemental Fig. S5).

Fig. 4C shows that the change of modification profiles on the 1-50 aa piece are similar to those observed for intact H3 upon Gcn5 deletion (Fig. 3, A and B). The relative abundance of peaks with +84, +126, and +168 Da were decreased dramatically in gcn5{Delta} cells, whereas the +42 Da peak remains much the same. ECD of the +42 Da peak of WT and gcn5{Delta} cells showed that it is a mixture of 20% of trimethylation on Lys4 and 80% trimethylation on Lys36. We further characterized the +84, +126, and +168 Da peaks in WT cells by ECD. The results showed that there is a mixture of "PTM isomers" in each peak. From the +42 Da peak to the +168 Da species, we observed that Lys4 trimethylation increased from 10 to 80% (Fig. 4D). Specifically, the MS/MS-based assay quantified the amount of Lys4 trimethylation on the 0, 1, 2, and 3 acetylation states as 10, 55, 75, and 80%, respectively (Table 1). In going from 0 to 3 acetylations, the distribution of acetylation occupancies for each discrete state was semiquantitatively determined (Table 1). These results revealed that higher degrees of trimethylation level on Lys4 are associated with higher degrees of acetylation.


View this table:
[in this window]
[in a new window]

 
TABLE 1
Modification level at different lysine residues on H3 from 0 Ac to 3 Ac state

 


Figure 5
View larger version (29K):
[in this window]
[in a new window]

 
FIGURE 5.
Comparison of the modifications at different lysine residues of H3 in WT and gcn5{Delta} cells. A, change of modification on fragment ion c10, which contains modification information on Lys4 and Lys9. B, peak splitting of the c10 +42 Da peak in A due to the presence of both acetylation (42.0106 Da) and trimethylation (42.047 Da). The low m/z peak represents acetylation from Lys9, and the high m/z peak represents trimethylation from Lys4. C-E, change of modification on Lys4, Lys79, and Lys56, respectively.

 
To streamline analysis of H3 1-50 aa from gcn5{Delta} cells, we combined all HPLC peaks of 1-50 aa and did bulk ECD. This showed that the acetylation levels on Lys9 (Fig. 5A) and Lys14 (supplemental Fig. S4A) each decreased by ~40%. The acetylation levels on Lys9 and Lys14 were determined through analyses of the c10 and c17 fragment ions, respectively. Although the mass changes due to trimethylation and acetylation are very close, they are readily distinguished by accurate mass measurements on the high resolution FTMS. As seen in Fig. 5B, the +42 Da peak of c10 showed peak splitting. The low m/z peak represents acetylation from Lys9, and the high m/z peak represents trimethylation from Lys4. Overall, there is ~10% acetylation occupancy for Lys18 and Lys23 (supplemental Fig. S4, B and C) in WT cells, but neither of them were observed in gcn5{Delta} cells. A change in the level of methylation at Lys4 and Lys79 was also observed. Trimethylation on Lys4 decreased about 30% (Fig. 5C), whereas trimethylation on Lys79 increased about 25% (Fig. 5D). Acetylation on Lys56 (Fig. 5E) and methylation on Lys36 and Lys27 remained the same in gcn5{Delta} cells (supplemental Fig. S4, D and E). The quantitative change of acetylation and methylation levels on each lysine residue is summarized in Fig. 6. Since Gcn5 is a HAT, the decrease of overall acetylation level on H3 is expected in {Delta}gcn5 cells. Here, the observed decrease of Lys4 trimethylation level also demonstrates that Lys4 methylation and acetylation levels on H3 are regulated in reciprocal fashion in vivo.

Set1 Mutants—To further characterize the relationship between trimethylation at Lys4 and acetylation on the same H3 molecule, we explored the changes in PTM patterning on H3 from different Set1 mutant cells. Set1 has been shown to be the sole methyltransferase responsible for H3 Lys4 mono-, di-, and trimethylation in yeast (29, 41-44). Its N-terminal truncated form (829-1080 aa) lacks trimethylation ability on Lys4 but still maintains normal levels of mono- and dimethylation (30).

Fig. 7, A and B, shows mass spectra of intact H3 and Glu-C-digested H3 (1-50 aa), respectively, from the parental strain and Set1 mutants. Although the broadband MS showed dramatic changes of modifications on H3 for the mutants, ion fragmentation was required to localize the changes to specific sites. Bulk ECD was performed on the 1-50 aa piece of H3 as described above, and the results from signature fragment ions reporting on lysines 4, 9, 14, 18, and 23 are summarized graphically in Fig. 7D and supplemental Fig. S6. The c4 fragment ion from ECD reporting on the Lys4 modification (Fig. 7C) showed that in Set1-(829-1080) cells, Lys4 mono- and dimethylation still existed, but trimethylation totally disappeared (Fig. 7C, middle). In set1{Delta} cells, only unmodified forms of Lys4 were observed; all of the methylated forms were absent (Fig. 7C, bottom). Fragment ion c10 (Fig. S6A) in combination with c4 provides information on Lys9 and showed that Lys9 was acetylated. Fragment ions c17 and c18 (Fig. S6, B and C) contain information on Lys14 and Lys18, respectively. Fig. S6B showed that the +84 Da peak was not observed in Set1-(829-1080) cells and decreased more than 50% in set1{Delta} cells. Through a procedure for internal calibration to boost mass accuracy, the +84 Da peak was shown to be a combination of Lys9 and Lys14 acetylation in set1{Delta} cells, whereas it is mainly a combination of Lys4 trimethylation and Lys14 acetylation in the WT cells. Fig. S6C showed that the +126 Da peak was missing in both Set1 mutants, whereas it was observed in WT cells. The +126 Da peak contains Lys4 trimethylation and acetylation at Lys14 and Lys18. These results showed that Lys4 trimethylation is required for the subsequent Lys14 and Lys18 acetylation. Since this particular modification form that has Lys4 trimethylation and Lys14 and Lys18 acetylation was not observed in both Set1 mutants, it can be concluded that it is trimethylation and not mono- or dimethylation that predominantly engages the acetylation machinery to place activating acetylation marks at Lys14 and Lys18. No significant change of overall modification level on Lys23, Lys27, and Lys36 was observed (supplemental Fig. S6). Although in WT type cells, Lys23 is 100% acetylated when Lys4 is highly trimethylated (Table 1), we did not obtain enough information about the correlation between them from these bulk ECD results because of the excessive complexity of the data. In order to increase the dynamic range for the detection of minor forms, we compared the ECD results of the +126 Da peak of 1-50 aa of H3 from WT and set1{Delta} cells. As shown in supplemental Fig. S7, in set1{Delta} cells, the peak with Lys4 trimethylation plus Lys14 and Lys23 acetylation disappeared. This result showed that with the loss of Lys4 trimethylation, Lys23 cannot be added to this particular modification form.


Figure 6
View larger version (25K):
[in this window]
[in a new window]

 
FIGURE 6.
Change of acetylation (A) and methylation (B) levels at different lysine residues of histone H3 in WT and gcn5{Delta} cells.

 
Gcn5-containing Protein ComplexesIn vitro studies have shown that Gcn5 alone does not acetylate H2B; however, in the context of protein complexes such as SAGA, it might be capable of directly acetylating H2B or affecting the function of other HATs, which could acetylate H2B. In addition to SAGA, several other protein complexes, such as ADA and SLIK, have also been discovered to contain Gcn5 (45). Gcn5 may have different or overlapping functions in those protein complexes through protein interactions. In order to verify that, we compared the change of histone modification profiles upon disruption of each protein complex. Previous studies have shown that Spt7 is an essential component of SAGA (46). Other proteins, such as Ahc1 and Rtg2, are found to be required for the integrity of ADA and SLIK protein complexes (47). Using the method described here, histone profiles were obtained from each of these mutants. Fig. 8 reveals that although the relative abundance of different modification forms was altered compared with WT, H2B and H3 were still highly modified after knocking out one protein complex. This result suggests that considerable redundancy exists between Gcn5-containing protein complexes or possibly other types of HATs that can compensate for the loss of HAT function of these specific types of Gcn5 complexes.

N-terminal Acetyltransferases—With only N-terminal acetylation of H2B left unaffected by Gcn5 knock-out, we investigated the effect of different N-terminal acetyltransferases on histones. Previous studies have shown that Ard1 and Nat1 are H2B N-terminal acetyltransferases, with Nat4 known to acetylate H4 and H2A (32, 48). Top down MS data of histones from nat1{Delta} cells showed no change in acetylation levels on H2B and other histones (data not shown). MS data from ard1{Delta} cells revealed a dramatic increase of unmodified H2B over the monoacetylated form (Fig. 8A, second row from top). MS/MS analysis of this monoacetylated form of H2B by ECD showed residual N-terminal acetylation exclusively (data not shown). This indicates that Ard1 is the major H2B N-terminal acetyltransferase, and there exists one or more unknown N-terminal acetyltransferases. The H3 modification pattern was also dramatically changed in ard1{Delta} cells (Fig. 8B, second row from top). MS data of histones from nat4{Delta} showed the increase of H4 and H2A unacetylated forms, consistent with prior studies (32, 48).


    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Histone Detection and MS/MS with Minimal Bias—This is the first implementation of high resolution "top down" mass spectrometry on yeast histones and allowed characterization of more than 50 distinct molecular forms arising from multiple modifications of the yeast core histones from wild type and mutant cell lines. In addition to establishing a definitive "basis set" of expressed yeast histones with minimal bias (i.e. detection of intact histone forms generally), this global view of bulk chromatin allows quantitative assessment of all major forms of each histone upon mutation (or other perturbation), with MS/MS allowing direct connection of intact forms with a quantitative readout of PTM occupancy at specific sites (28). Since this particular approach determines both the changes of abundance for multiply modified forms and the localization of each modification to a specific amino acid residue, this study overcomes some of the limitations of antibodies by using MS of intact histones (and the N-terminal 1-50 aa piece of histone H3). Antibodies are good for PTMs in isolation, but they generally cannot accurately account for changes involving combinations of modifications. In addition, since different antibodies have different affinities, accurate quantitation of changes in the relative abundance of different PTMs is not possible. Although top down mass spectrometry can overcome these problems, one limitation relative to antibodies is that of limit of detection. The methodology employed here has the ability to detect species at 0.1-1% relative abundance in bulk chromatin, with the quantitative picture of histones precise to ~5% using MS/MS data of moderate quality (28). For the direct comparison of histone H3 from WT and gcn5{Delta} cells, the MS results qualitatively match those from acid urea gels and Western analysis of selected PTM combinations (Fig. 3).


Figure 7
View larger version (33K):
[in this window]
[in a new window]

 
FIGURE 7.
Comparison of H3 modification at intact, Glu-C-digested and fragment level from WT, Set1-(829-1080), and set1{Delta} cells. A and B, change of modification pattern on intact H3 and Glu-C-digested H3, respectively. C, change of Lys4 methylation in WT and Set1 mutants. D, representation of the change of modifications on Lys4, Lys9, Lys14, Lys18, and Lys23 detected in MS/MS experiments from WT and set1{Delta} cells. In set1{Delta} cells, mono-, di-, and trimethylation on Lys4 disappeared. The forms that contain Lys4 trimethylation, Lys14 acetylation, and Lys18 or Lys23 acetylation were not observed in set1{Delta} cells.

 
Effects of Gcn5 on All Core Histones—Due to the inherent limitations of antibodies discussed above, previous studies that were mostly based on antibodies did not show a comprehensive view of the effects of Gcn5 on all core histones. By using top down strategies described in this paper, we reexamined its effect on all core histones with minimal bias. The results showed that knock-out of Gcn5 had slight effects on H4 and H2A but dramatically decreased acetylation levels on histone H2B and H3. Further investigation using tandem mass spectrometry localized the change of modification to individual amino acid residues. The results demonstrated that for H2B, Gcn5 is the major HAT that affects all acetylation sites except for the N terminus. Ard1 was shown to be the major N-terminal acetyltransferase for H2B. On H3, not only acetylation on Lys9, Lys14, Lys18, and Lys23 were affected by Gcn5 but also the methylation levels on Lys4 and Lys79. The correlation of methylation and acetylation on H3 is discussed further below.

Since Gcn5 exists in different protein complexes, such as SAGA, SLIK, and ADA, it may have different effects on histone proteins in different protein complexes. However, disruption of each individual protein complex did not show a dramatic change of modification on H2B and H3. This may due to the redundancy of function among different Gcn5-containing complexes or possibly other HATs. Here, a "global" view prevents us from determining whether PTM changes are confined to only a portion of the genome. However, with Gcn5 knocked out, HAT function of all of the protein complexes was lost, resulting in a dramatic decrease of acetylation on H2B and H3.

Linking Methylation with Acetylation on the Same H3 Tail—There are three lines of evidence that reveal the interplay of acetylation and Lys4 trimethylation on the H3 tail, with the quantitation of this reciprocal relationship afforded by our approach a novel feature of this work. For WT yeast histone H3, the FTMS-based assay quantified the direct link between increases of Lys4 trimethylation and the 0, 1, 2, and 3 acetylation states of histone H3. The results reveal a swing from 10, 55, 75 to 80% trimethylation levels on the 0, 1, 2, and 3 acetylation states, respectively. This work therefore meshes well with assertions in recent reviews (49-52) and other work (39, 53) proposing a high correlation between Lys4 trimethylation and hyperacetylation on H3.


Figure 8
View larger version (37K):
[in this window]
[in a new window]

 
FIGURE 8.
Comparison of all core histone modification patterns in WT, ard1{Delta}, spt7{Delta}, rtg2{Delta}, and ahc1{Delta} cells. Columns A, B, C, and D compare H2B, H3, H4, and H2A, respectively, in all of the mutants.

 


Figure 9
View larger version (31K):
[in this window]
[in a new window]

 
FIGURE 9.
The genome-wide acetylation levels of H3 at Lys14 versus trimethylation levels of H3 at Lys4 in 3,581 intergenic regions of WT yeast cells. Each data point represents an intergenic region. The x axis is the log2 transformed trimethylation level of Lys4, and the y axis is the log2 transformed acetylation level of Lys14. The acetylation and methylation levels are obtained from ChIP-on-chip results.

 
Our results from deletion of gcn5{Delta} and set1{Delta} further characterize the interplay between acetylation and Lys4 trimethylation on H3 and are largely consistent with previous studies. In gcn5{Delta} cells, the expected decrease of acetylation levels (primarily on Lys9, Lys14, Lys18, and Lys23 of H3) were accompanied by an overall drop of 30% in trimethylation level on Lys4. Zhang et al. (39) has shown that a higher level of methylation of Lys4 and Lys79 is associated with hyperacetylation on H3. Since the absence of Gcn5 results in decreased acetylation, lower methylation levels on Lys4 and Lys79 are expected. However, our observation of a 20% decrease of trimethylation on Lys79 in gcn5{Delta} cells is inconsistent with the study of Zhang et al. (39). The results from Set1 mutants also showed that loss of Lys4 trimethylation, not mono- or dimethylation, caused the loss of detectable Lys14 and Lys18 or Lys23 acetylation on the same H3 tail. Interestingly, previous studies have shown that some of the Lys4 methyl readers reside within different chromatin remodeling complexes that also have acetyltransferase activities. For example, Chd1 and Yng1, two major trimethyl Lys4 binding proteins in yeast, are components of SAGA/SLIK and NuA3, respectively (54, 55). Loss of Lys4 trimethylation may cause the loss of binding sites for those protein complexes, which can acetylate Lys14 and Lys18 or Lys23 to further activate transcription. These results are consistent with a more potent role for Lys4 trimethylation (versus mono- or dimethylation) in transcriptional activation.

Integrating Diverse Data Types: Linking K4me3 with Acetylation at Thousands of Loci—Correlation of recent ChIP-on-chip results (32) with our global histone modification readouts by mass spectrometry was initiated by creating the scatter plot between genome-wide acetylation levels at Lys14 and trimethylation levels at Lys4 of H3 in 3,581 intergenic regions of WT yeast cells (Fig. 9). The acetylation level of Lys14 and trimethylation level of Lys4 on H3 exhibit a strong positive linear relationship (Pearson correlation coefficient 0.72) after taking log2 transformation of their values. From our studies of acetylation site usage, we found that Lys14 and Lys23 are the most occupied acetylation sites and correlate tightly with the increase in Lys4 trimethylation level (Table 1). The results showed that Lys9 acetylation correlates less tightly with Lys4 trimethylation (Table 1); indeed, an analogous plot to Fig. 9 using Lys9 acetylation gives a Pearson correlation coefficient at 0.42. Since Lys23 acetylation has not been studied in these ChIP-on-chip experiments, the statistical results are unavailable, but from our mass spectrometry results, we believe that it should also correlate well with Lys4 trimethylation. The reciprocal relationship between Lys14 acetylation and Lys4 trimethylation has also been shown in the gcn5{Delta} and set1{Delta} cells (discussed above). One novel feature of our work is that data in Fig. 7D and supplemental Fig. S7 showed that Lys14 acetylation and Lys4 trimethylation co-exist on the same H3 tail and that the loss of Lys4 trimethylation caused the linked disappearance of acetylation on Lys14.

Yeast provides an excellent system for studying the nature of transcriptionally active chromatin, as a large percentage of the chromatin is in a transcriptional competent conformation (86% of the genome encodes genes). This makes it especially interesting to examine the levels of histone acetylations. In yeast cells besides Gcn5, there are many other HATs which also exhibit site and histone specificity. Currently, because of the advantage of yeast genetics, the knock-out library makes it convenient to study the effects of all yeast histone modifying enzymes. In combination with the mass spectrometry and histone extraction methods described here, it enables us to investigate the substrate specificity of all the known HATs on histones, which will unravel how HATs work together to produce specific acetylation patterns. The acetylation levels are maintained by the balance of HATs and histone deacetylases. However, until now the interplay of HATs and histone deacetylases has remained unclear. The study of histone deacetylase substrate specificity and the changes of acetylation patterns after double mutation of certain HATs and histone deacetylases will elucidate the correlations between them.


    FOOTNOTES
 
* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Back

Formula The on-line version of this article (available at http://www.jbc.org) contains supplemental Figs. S1-S7. Back

1 Supported by a Chia-chen Chu Kang fellowship through the School of Chemical Sciences at the University of Illinois. Back

2 The laboratory of this author was supported by Roy J. Carver Charitable Trust Grant 04-76 and March of Dimes Basil O'Connor Award 5-FY05-1232. Back

3 To whom correspondence should be addressed: Dept. of Chemistry, University of Illinois, 600 S. Mathews, 53 Rodger Adams Laboratory, Urbana, IL 61801. Tel.: 217-244-3927; Fax: 217-244-8068; E-mail: kelleher{at}scs.uiuc.edu.

4 The abbreviations used are: PTM, post-translational modification; HAT, histone acetyltransferase; ECD, electron capture dissociation; RPLC, reverse phase liquid chromatography; ESI, electrospray ionization; FTMS, Fourier transform mass spectrometry; WT, wild type; HPLC, high pressure liquid chromatography; aa, amino acids; ChIP, chromatin immunoprecipitation; SAGA, Spt-Ada-Gcn5-acetyltransferase. Back


    ACKNOWLEDGMENTS
 
We thank Dr. Scott Briggs for Set1 mutants.



    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Luger, K., Mader, A. W., Richmond, R. K., Sargent, D. F., and Richmond, T. J. (1997) Nature 389, 251-260[CrossRef][Medline] [Order article via Infotrieve]
  2. Margueron, R., Trojer, P., and Reinberg, D. (2005) Curr. Opin. Genet. Dev. 15, 163-176[CrossRef][Medline] [Order article via Infotrieve]
  3. Zhang, Y., and Reinberg, D. (2001) Genes Dev. 15, 2343-2360[Free Full Text]
  4. Jenuwein, T., and Allis, C. D. (2001) Science 293, 1074-1080[Abstract/Free Full Text]
  5. Strahl, B. D., and Allis, C. D. (2000) Nature 403, 41-45[CrossRef][Medline] [Order article via Infotrieve]
  6. Roth, S. Y., Denu, J. M., and Allis, C. D. (2001) Annu. Rev. Biochem. 70, 81-120[CrossRef][Medline] [Order article via Infotrieve]
  7. Chicoine, L. G., Schulman, I. G., Richman, R., Cook, R. G., and Allis, C. D. (1986) J. Biol. Chem. 261, 1071-1076[Abstract/Free Full Text]
  8. Sterner, D. E., and Berger, S. L. (2000) Microbiol. Mol. Biol. Rev. 64, 435-459[Abstract/Free Full Text]
  9. Suka, N., Suka, Y., Carmen, A. A., Wu, J., and Grunstein, M. (2001) Mol. Cell 8, 473-479[CrossRef][Medline] [Order article via Infotrieve]
  10. Brownell, J. E., Zhou, J., Ranalli, T., Kobayashi, R., Edmondson, D. G., Roth, S. Y., and Allis, C. D. (1996) Cell 84, 843-851[CrossRef][Medline] [Order article via Infotrieve]
  11. Kuo, M. H., Brownell, J. E., Sobel, R. E., Ranalli, T. A., Cook, R. G., Edmondson, D. G., Roth, S. Y., and Allis, C. D. (1996) Nature 383, 269-272[CrossRef][Medline] [Order article via Infotrieve]
  12. Grant, P. A., Duggan, L., Cote, J., Roberts, S. M., Brownell, J. E., Candau, R., Ohba, R., Owen-Hughes, T., Allis, C. D., Winston, F., Berger, S. L., and Workman, J. L. (1997) Genes Dev. 11, 1640-1650[Abstract/Free Full Text]
  13. Grant, P. A., Eberharter, A., John, S., Cook, R. G., Turner, B. M., and Workman, J. L. (1999) J. Biol. Chem. 274, 5895-5900[Abstract/Free Full Text]
  14. Zhang, W. Z., Bone, J. R., Edmondson, D. G., Turner, B. M., and Roth, S. Y. (1998) EMBO J. 17, 3155-3167[CrossRef][Medline] [Order article via Infotrieve]
  15. Kuo, M. H., Zhou, J. X., Jambeck, P., Churchill, M. E. A., and Allis, C. D. (1998) Genes Dev. 12, 627-639[Abstract/Free Full Text]
  16. Gregory, P. D., Schmid, A., Zavari, M., Lui, L., Berger, S. L., and Horz, W. (1998) Mol. Cell 1, 495-505[CrossRef][Medline] [Order article via Infotrieve]
  17. Vogelauer, M., Wu, J. S., Suka, N., and Grunstein, M. (2000) Nature 408, 495-498[CrossRef][Medline] [Order article via Infotrieve]
  18. Kurdistani, S. K., Tavazoie, S., and Grunstein, M. (2004) Cell 117, 721-733[CrossRef][Medline] [Order article via Infotrieve]
  19. Huisinga, K. L., and Pugh, B. F. (2004) Mol. Cell 13, 573-585[CrossRef][Medline] [Order article via Infotrieve]
  20. Roh, T. Y., Ngau, W. C., Cui, K. R., Landsman, D., and Zhao, K. J. (2004) Nat. Biotechnol. 22, 1013-1016[CrossRef][Medline] [Order article via Infotrieve]
  21. Meng, F. Y., Cargile, B. J., Patrie, S. M., Johnson, J. R., McLoughlin, S. M., and Kelleher, N. L. (2002) Anal. Chem. 74, 2923-2929[Medline] [Order article via Infotrieve]
  22. Pesavento, J. J., Kim, Y. B., Taylor, G. K., and Kelleher, N. L. (2004) J. Am. Chem. Soc. 126, 3386-3387[CrossRef][Medline] [Order article via Infotrieve]
  23. Zubarev, R. A., Horn, D. M., Fridriksson, E. K., Kelleher, N. L., Kruger, N. A., Lewis, M. A., Carpenter, B. K., and McLafferty, F. W. (2000) Anal. Chem. 72, 563-573[Medline] [Order article via Infotrieve]
  24. Zubarev, R. A. (2004) Curr. Opin. Biotechnol. 15, 12-16[CrossRef][Medline] [Order article via Infotrieve]
  25. Boyne, M. T., Pesavento, J. J., Mizzen, C. A., and Kelleher, N. L. (2006) J. Proteome Res. 5, 248-253[CrossRef][Medline] [Order article via Infotrieve]
  26. Siuti, N., Roth, M. J., Mizzen, C. A., Kelleher, N. L., and Pesavento, J. J. (2006) J. Proteome Res. 5, 233-239[CrossRef][Medline] [Order article via Infotrieve]
  27. Thomas, C. E., Kelleher, N. L., and Mizzen, C. A. (2006) J. Proteome Res. 5, 240-247[CrossRef][Medline] [Order article via Infotrieve]
  28. Pesavento, J. J., Mizzen, C. A., and Kelleher, N. L. (2006) Anal. Chem. 78, 4271-4280[Medline] [Order article via Infotrieve]
  29. Briggs, S. D., Bryk, M., Strahl, B. D., Cheung, W. L., Davie, J. K., Dent, S. Y. R., Winston, F., and Allis, C. D. (2001) Genes Dev. 15, 3286-3295[Abstract/Free Full Text]
  30. Fingerman, I. M., Wu, C. L., Wilson, B. D., and Briggs, S. D. (2005) J. Biol. Chem. 280, 28761-28765[Abstract/Free Full Text]
  31. Pesavento, J. J., Garcia, B. A., Streeky, J. A., Kelleher, N. L., and Mizzen, C. A. (2007) Mol. Cell Proteomics, in press
  32. Mullen, J. R., Kayne, P. S., Moerschell, R. P., Tsunasawa, S., Gribskov, M., Colavito-Shepanski, M., Grunstein, M., Sherman, F., and Sternglanz, R. (1989) EMBO J. 8, 2067-2075[Medline] [Order article via Infotrieve]
  33. Pokholok, D. K., Harbison, C. T., Levine, S., Cole, M., Hannett, N. M., Lee, T. I., Bell, G. W., Walker, K., Rolfe, P. A., Herbolsheimer, E., Zeitlinger, J., Lewitter, F., Gifford, D. K., and Young, R. A. (2005) Cell 122, 517-527[CrossRef][Medline] [Order article via Infotrieve]
  34. Yuan, G. Z., Ma, P., Zhong, w., and Liu, J. S. (2006) Genome Biol. 7, 70[CrossRef]
  35. Waterborg,